Nutrition 21 and General Nutrition Corporation Announce Settlement of Patent Infringement Suit

Biz Yahoo:

General Nutrition Corporation (GNC) announced today that they have settled the patent litigation between the companies presently pending in federal court in Texas. Specific terms of the settlement were not disclosed, except for GNC’s acknowledgement that the three patents in the litigation are valid.

The litigation centered around Nutrition 21’s claims that GNC was inducing infringement of Nutrition 21’s patents (U.S. Patent Nos. 5,087,623; 5,087,624; and, 5,175,156), by advertising and promoting certain products containing chromium picolinate for the uses covered by Nutrition 21’s patents. These patents cover methods of administering chromium picolinate to reduce hyperglycemia and stabilize serum glucose, increase lean body mass and reduce body fat, and prevent undesirable high levels of blood serum lipids.

GNC has more than 4,800 retail locations throughout the United States (including more than 1,000 franchise and more than 1,200 Rite Aid store-within-a-store locations) and franchise operations in 46 international markets.

Featured Opportunities

Related Stories